• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthDigital Health

Exclusive: This Startup Wants to Score You Cheap Prescription Drugs. Now It’s Offering Home Delivery

By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
By
Sy Mukherjee
Sy Mukherjee
Down Arrow Button Icon
October 2, 2018, 8:00 AM ET

Digital health startup Blink Health will now provide customers free home delivery for its prescription drug service, which offers thousands of commonly used treatments at hugely discounted prices, the company tells Fortune.

Blink Health co-founders (and brothers) Geoffrey and Matthew Chaiken were part of Fortune‘s most recent class of 40 Under 40 entrepreneurs. The company’s aim is to offer an e-commerce based solution to one of America’s most persistent and controversial medical problems: The staggering cost of prescription drugs.

“We provide Americans access to significant savings on their prescriptions, and now we’re offering another convenient way for getting their medications filled,” said Blink Health co-founder and CEO Geoffrey Chaiken in a statement announcing the new home delivery option. “We’re adding home delivery because modern retail requires consumer choice and the integration of online, physical retail, and delivery.”

Up until now, the service has worked as a free pickup model: You could search for whatever prescription you needed through Blink’s site or app, select your preferred low-cost deal on the medicine, and then have it filled at a local participating pharmacy for later pickup. The new offering allows shipment straight to a customer’s home. (There are no associated membership fees for the service.)

 

Courtesy of Blink Health
Courtesy of Blink Health

The basic idea behind Blink Health is to bypass middlemen in the drug supply chain—such as pharmacy benefits managers (PBMs) and insurers—in order to cut deals on prescription medications (and specifically the generic drugs that the vast majority of people use). That process can save customers money while also offering incentives to participating pharmacies, according to the firm—of which there are more than 33,000 local ones, including major chains like Albertsons, Kroger’s, Safeway, and Walmart.

Pharmacy benefits managers like Express Scripts and others have come under scrutiny in recent years (including by Congress and the Trump administration) for their potential role in driving up drug prices. Such companies negotiate discounts with drug makers on a medication’s list price; but critics point out that these negotiated discounts largely line PBMs’ pockets without passing much in the way of savings onto consumers.

So, Blink’s strategy is to simply cut out the go-between with the help of tech and negotiating power. It offers participating pharmacies an assured rate in exchange for negotiating lower prices. The system intentionally doesn’t accept insurance but can still provide consumers with a lower out-of-pocket cost for their prescription meds, whether they be common cholesterol, diabetes, or other drugs.

 

Courtesy of Blink Health
Courtesy of Blink Health

CEO Geoffrey Chaiken and other Blink Health executives Fortune spoke with were harshly critical of the PBM industry (CVS and Walgreens, two retail pharmacy giants, have cut ties with the company). Which adds some irony to the fact that one of Chaiken’s major coups was getting Susan Lang, a veteran and senior vice president of Express Scripts, to join what is in many ways the enemy.

“For a long time, PBMs really had a critical space,” says Lang, who is now the chief strategy officer at Blink Health. “The motto at Express was: Make drugs safer and more affordable. By the time I left, I think that was dramatically starting to change. Those incentives weren’t aligning anymore.”

Chaiken also enlisted the likes of Robert Birge, the former chief marketing officer at Kayak and all-around e-commerce whiz, as Blink’s own marketing chief. Between Lang and Birge, Chaiken has assembled an eclectic team that has a grasp on the pharmaceutical supply chain and the ins-and-outs of digital commerce alike—which may also explain why Blink’s intriguing progression.

“Our view is that this needs to be a multi-channel strategy,” says Chaiken. “We started as the opposite of a lot of other people… We started with retail, in-person pickup, and then went online and home delivery.”

Given the highly personal—and medically critical, often time-sensitive—nature of picking up prescriptions, the strategy may prove noteworthy.

Subscribe to Brainstorm Health Daily, our newsletter about the most exciting health innovations.

About the Author
By Sy Mukherjee
See full bioRight Arrow Button Icon

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

PoliticsModerna
FDA backtracks and agrees to review Moderna mRNA flu vaccine after initial rejection
By Lauran Neergaard and The Associated PressFebruary 18, 2026
16 hours ago
Healthsleep
The 4 Best Bed Frames of 2026: Expert Tested
By Christina SnyderFebruary 18, 2026
19 hours ago
Successthe future of work
As boomer and Gen X bosses retire, working from home will make a major comeback, new research predicts—and you have work-life balance loving Gen Z to thank
By Orianna Rosa RoyleFebruary 17, 2026
2 days ago
HealthHealth
Confronting Asia’s growing rate of chronic conditions means tackling cultural issues as much as medical ones
By Stuart A. SpencerFebruary 15, 2026
4 days ago
Susan Blumenthal
AICancer
Meet the American spies who helped mammograms save more lives
By Erik GermanFebruary 15, 2026
4 days ago
HealthDietary Supplements
5 Best Nootropics of 2026: Expert Reviewed Supplements
By Christina SnyderFebruary 13, 2026
6 days ago

Most Popular

placeholder alt text
AI
Thousands of CEOs just admitted AI had no impact on employment or productivity—and it has economists resurrecting a paradox from 40 years ago
By Sasha RogelbergFebruary 17, 2026
2 days ago
placeholder alt text
Asia
Bill Gates pulls out of India's AI summit at the last minute, in the latest blow to an event dogged by organizational chaos
By Beatrice NolanFebruary 19, 2026
5 hours ago
placeholder alt text
Personal Finance
You need $2 million to retire and 'almost no one is close,' BlackRock CEO warns, a problem that Gen X will make 'harder and nastier'
By Sydney LakeFebruary 17, 2026
2 days ago
placeholder alt text
Economy
Top Trump advisor furious about true cost of tariffs being revealed, vows to punish New York Fed for ‘worst paper’ ever in history
By Jake AngeloFebruary 18, 2026
16 hours ago
placeholder alt text
Personal Finance
Current price of silver as of Wednesday, February 18, 2026
By Joseph HostetlerFebruary 18, 2026
1 day ago
placeholder alt text
Economy
Trump crackdown drives 80% plunge in immigrant employment, reshaping labor market, Goldman says
By Nick LichtenbergFebruary 17, 2026
2 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.